腹腔镜下结直肠癌根治术患者麻醉中靶控输注舒芬太尼和瑞芬太尼复合麻醉对其恢复状况影响分析.docVIP

腹腔镜下结直肠癌根治术患者麻醉中靶控输注舒芬太尼和瑞芬太尼复合麻醉对其恢复状况影响分析 　　[摘要] 目的 分析腹腔镜下结直肠癌根治术患者麻醉中靶控输注舒芬太尼和瑞芬太尼复合麻醉对其恢复状况产生的具体影响。方法 回顾性分析该院2015年6月―2016年6月期间收治的70例腹腔镜下结直肠癌根治术患者的临床资料，根据双盲法将其分为研究组（35例）与对照组（35例）。研究组35例腹腔镜下结直肠癌根治术患者给予靶控输注舒芬太尼和瑞芬太尼复合麻醉；对照组35例腹腔镜下结直肠癌根治术患者给予靶控输注舒芬太尼麻醉；对比两组腹腔镜下结直肠癌根治术患者的拔管时间、苏醒时间与不良反应发生率。结果 研究组35例腹腔镜下结直肠癌根治术患者的不良反应发生率、苏醒时间、拔管时间依次为5.71%、（8.86±4.57）min、（13.25±3.27）min，对照组35例腹腔镜下结直肠癌根治术患者的不良反应发生率为25.71%、（17.15±7.92）min、（23.14±4.48）min；两组对比差异有统计学意义（P0.05）。结论 腹腔镜下结直肠癌根治术患者麻醉中靶控输注舒芬太尼和瑞芬太尼复合麻醉对其恢复状况具有促进作用，值得在临床麻醉工作中推广运用。 　　[关键词] 腹腔镜；结直肠癌根治术；靶控输注；舒芬太尼；瑞芬太尼 　　[中图分类号] R614 [文献标识码] A [文章编号] 1674-0742（2016）12（c）-0115-03 　　[Abstract] Objective Analysis of anesthesia in patients with laparoscopic colorectal cancer radical target controlled infusion sufentanil and fentanyl compound anesthesia of the specific influence on the recovery. Methods Retrospective analysis in June 2015 to June 2016 treated 70 cases of clinical data of laparoscopic colorectal cancer patients with radical prostatectomy， according to the double blind method divided into research group （35 cases） and control group （35 cases）. Group of 35 cases of laparoscopic colorectal cancer treated with target controlled infusion of sufentanil and fentanyl compound anesthesia. The control group of 35 cases of laparoscopic colorectal cancer treated with target controlled infusion of sufentanil anesthesia； Comparison of two groups of patients with laparoscopic colorectal cancer radical extubation time， wake up time and the incidence of adverse reactions. Results Group of 35 cases of patients with laparoscopic colorectal cancer radical incidence of adverse reactions， wake up of time， extubation time in turn （5.71%），（8.86±4.57）min and（13.25±3.27）min， the control group of 35 cases of patients with laparoscopic colorectal cancer radical the incidence of adverse reactions was 25.71%， （17.15±7.92）min and（23.14±4.48）min； The difference between the two groups was statistically significant（P 0.05）. Conclusion Anesthesia in pati